Research Portal

Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer

Research output: Contribution to journal › Article › peer-review

Standard Standard

Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer. / Rai, N.; Campaneria, R.; Snell, K. et al.
In: Cochrane Library, Vol. 2015, No. 12, CD011964, 07.12.2015.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Rai, N, Campaneria, R, Snell, K, Mallett, S, Bayliss, SE, Neal, RD, Balogun, M, Kehoe, S, Deeks, JK, Sundar, S & Davenport, C 2015, 'Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer', Cochrane Library, vol. 2015, no. 12, CD011964. https://doi.org/10.1002/14651858.CD011964

APA

Rai, N., Campaneria, R., Snell, K., Mallett, S., Bayliss, S. E., Neal, R. D., Balogun, M., Kehoe, S., Deeks, J. K., Sundar, S., & Davenport, C. (2015). Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer. Cochrane Library, 2015(12), Article CD011964. https://doi.org/10.1002/14651858.CD011964

CBE

Rai N, Campaneria R, Snell K, Mallett S, Bayliss SE, Neal RD, Balogun M, Kehoe S, Deeks JK, Sundar S, et al. 2015. Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer. Cochrane Library. 2015(12):Article CD011964. https://doi.org/10.1002/14651858.CD011964

MLA

Rai, N. et al. "Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer". Cochrane Library. 2015. 2015(12). https://doi.org/10.1002/14651858.CD011964

VancouverVancouver

Rai N, Campaneria R, Snell K, Mallett S, Bayliss SE, Neal RD et al. Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer. Cochrane Library. 2015 Dec 7;2015(12):CD011964. doi: 10.1002/14651858.CD011964

Author

Rai, N. ; Campaneria, R. ; Snell, K. et al. / Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer. In: Cochrane Library. 2015 ; Vol. 2015, No. 12.

RIS

TY - JOUR

T1 - Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer

AU - Rai, N.

AU - Campaneria, R.

AU - Snell, K.

AU - Mallett, S.

AU - Bayliss, S.E.

AU - Neal, R.D.

AU - Balogun, M.

AU - Kehoe, S.

AU - Deeks, J.K.

AU - Sundar, S.

AU - Davenport, C.

PY - 2015/12/7

Y1 - 2015/12/7

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To establish the accuracy of symptoms, ultrasound and biomarkers alone or in combination for the diagnosis of ovarian cancer in pre- and postmenopausal women. To compare the accuracy of different tests or test combinations. We will investigate the following sources of heterogeneity: Population Clinical setting (generalist/primary care/community/family practice) versus specialist setting (cancer unit/cancer centre/gynaecological oncology) Menopausal status Index tests Test positivity threshold Experience of the ultrasound test operator (general sonographers versus specialist interest) Target condition Histological subtype Study quality Case-control versus other study designs Study quality: for study participants not receiving surgery initially following a negative index test result: 12 months follow-up versus less than 12 months follow-up

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To establish the accuracy of symptoms, ultrasound and biomarkers alone or in combination for the diagnosis of ovarian cancer in pre- and postmenopausal women. To compare the accuracy of different tests or test combinations. We will investigate the following sources of heterogeneity: Population Clinical setting (generalist/primary care/community/family practice) versus specialist setting (cancer unit/cancer centre/gynaecological oncology) Menopausal status Index tests Test positivity threshold Experience of the ultrasound test operator (general sonographers versus specialist interest) Target condition Histological subtype Study quality Case-control versus other study designs Study quality: for study participants not receiving surgery initially following a negative index test result: 12 months follow-up versus less than 12 months follow-up

U2 - 10.1002/14651858.CD011964

DO - 10.1002/14651858.CD011964

M3 - Article

VL - 2015

JO - Cochrane Library

JF - Cochrane Library

SN - 1465-1858

IS - 12

M1 - CD011964

ER -